Nepafenac 0.1% eyedrops

DRUG3 trials

Sponsors

Università degli Studi di Brescia, Indonesia University, Pomeranian Medical University Szczecin

Conditions

Proliferative VitreoretinopathyPseudophakic Cystoid Macular EdemaRhegmatogenous Retinal DetachmentVitreous Inflammation

Phase 3

NSAIDs and PGE2 Levels in Vitrectomy Patients

CompletedNCT02361645

Università degli Studi di BresciaVitreous Inflammation

Start: 2014-03-31End: 2015-01-31Updated: 2015-02-12

Phase 4

Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy

CompletedNCT07162818

Indonesia UniversityProliferative Vitreoretinopathy, Rhegmatogenous Retinal Detachment

Start: 2021-04-28End: 2021-12-01Updated: 2025-09-09

Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract Phacoemulsification

CompletedNCT07696104

Pomeranian Medical University SzczecinPseudophakic Cystoid Macular Edema

Start: 2020-10-14End: 2024-05-22Updated: 2026-07-10